Skip to main content
. 2020 Jul 15;9(7):2245. doi: 10.3390/jcm9072245

Table 3.

Serum markers of preeclampsia and/or cardiovascular disease.

Physiologic Effects PE Non Pregnant Type CVD Ref
CRP Immunomodulation [82]
CHD, HF [83]
VEGF Pro-angiogenic [84]
Pro-vasculogenic Polymorphisms CHD [85]
sFlt-1 Anti-angiogenic [84]
CHD, HF [86]
sEng Anti-angiogenic [84]
CHD [87]
Gal-3BP Immunomodulation [88]
CHD [89]
Activin A Immunomodulation [90]
Apoptosis HT, CHD [91]
Leptin Immunomodulation [92]
angiogenetic CHD [93]
sE-selectin Immunomodulation [94]
HT [95]
ADAM 12 angiogenetic [96]
immunomodulation HT [97]
ADMA vasodilatation [98]
CHD, HF, HT [99]
PLGF Pro-angiogenic [84]
CHD, HF [86]
PAPP-A Proteolysis IGF-BP ↓ → ↑ [94,100]
CHD [101]
ADM Pro-angiogenic [102]
Vasodilatation AMI [103]
PP13 Immunomodulation [104]
Inhibin A Undetermined in pregnancy [90]
E3 Undetermined in pregnancy [105]
AFP Undetermined in pregnancy [100]
HbF A1M Immunomodulation [59]

Legend to Table 3: PE: Preeclampsia; CVD: Cardiovascular disease; ↑: High serum concentration; ↓: Low serum concentration; ↓ → ↑: Serum concentration changing from low to high; CHD: Coronary heart disease; HT: Hypertension; HF: Heart failure; AMI: Acute myocardial infarction; CRP: C-reactive protein; VEGF: Vascular endothelial growth factor; sFLT1:Soluble fms-like tyrosine kinase 1; sENG: Soluble endoglin; GAL-3BP: Galectin 3 binding protein; sE-selectin: Soluble E-selectin; ADAM12:A disintegrin and metalloproteinase 12; ADMA: Asymmetric dimethylarginine; PLGF: Placental growth factor; PAPP-A: Pregnancy-associated placental protein A; ADM: Adrenomedullin; PP13: Placental protein 13; E3: Estriol; AFP: Alpha fetoprotein; HbF: Fetal hemoglobin; A1M: Alfa-1-microglobulin.